Left Atrial Appendage Closure Device Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact
Discover trends, market shifts, and competitive outlooks for the left atrial appendage closure device industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Left Atrial Appendage Closure Device Market From 2025 To 2029?
In recent times, there has been a swift expansion in the market size of the left atrial appendage closure device. The projected growth is from $1.67 billion in 2024 to $2 billion in 2025, registering a compound annual growth rate (CAGR) of 19.5%. The increase in the historical span was influenced by factors such as the occurrence of atrial fibrillation, strategies developed for stroke prevention, existing clinical research and evidence, the advent of minimally invasive alternatives, the inclination of patients towards non-pharmacological options, the ageing population, and the proficiency and training of physicians.
In the coming years, the market size of the left atrial appendage closure device is anticipated to experience substantial growth. It is projected to expand to $3.74 billion in 2029 with a CAGR of 17.0%. The expansion during the forecast period is due to a rising global prevalence of atrial fibrillation, emphasis on preventing strokes in high-risk patients, increased patient awareness, assimilation into standard medical practice, and worldwide initiatives in managing cardiovascular diseases. The forecast period will see prevalent trends like the introduction of percutaneous closure techniques, advancements in the design of devices, a growing utilization of imaging technologies, a focus on less invasive methods, and customizing device selection based on patient anatomy.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp
What Are the Core Market Drivers Propelling Growth in the Left Atrial Appendage Closure Device Industry?
The increasing occurrence of atrial fibrillation is projected to drive the expansion of the left atrial appendage (LAA) closure device sector. Atrial fibrillation is a health issue defined by an erratic, typically quickened heartbeat, which arises when the atria, the heart’s upper compartments, fail to beat in a synchronized and rhythmic fashion. LAA closure devices principally serve to treat atrial fibrillation, mitigating stroke risks in patients suffering from this cardiac arrhythmia and inhibiting clot formation or discharge. For instance, according to an October 2022 report by the Centers for Disease Control and Prevention, a U.S. government agency, atrial fibrillation was the chief diagnosis in over 454,000 yearly hospital admissions, and the number of people with atrial fibrillation in the U.S. is predicted to reach 12.1 million by 2030. As such, the upsurge in atrial fibrillation cases is likely to boost the LAA closure device market’s growth prospects. The surge in the senior population is anticipated to further spur the growth of the LAA closure device market. The categorization of the senior population includes individuals aged 65 and above, underlining their unique health needs and age-related challenges. LAA closure devices can decrease the stroke risk that comes with atrial fibrillation, a condition typically found in older adults. For example, in 2023, a government agency based in Europe, Eurostat, disclosed that over 21% of the EU population in 2022 was aged 65 and over, with the median age reaching 44.4 years, meaning that half of the people were aged above this. This increasing geriatric population, therefore, is propelling the LAA closure device market’s growth.
How Is the Left Atrial Appendage Closure Device Market Segmented?
The left atrial appendage closure device market covered in this report is segmented –
1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Epicardial Left Atrial Appendage (LAA) Devices: Suture-Based Closure Devices, Ligation-Based Closure Devices, Clip-Based Closure Devices
2) By Endocardial Left Atrial Appendage (LAA) Devices: Plug-Based Closure Devices, Disc-Based Closure Devices, Mesh-Based Closure Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13474&type=smp
Which Regions Are Driving the Next Phase of the Left Atrial Appendage Closure Device Market Growth?
North America was the largest region in the left atrial appendage closure devices market in 2024. The regions covered in the left atrial appendage closure device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Left Atrial Appendage Closure Device Industry?
Leading entities in the left atrial appendage closure device market are spearheading innovation with products like Watchman FLX, designed to progress treatment for non-valvular atrial fibrillation (NVAF). These advancements provide patients an alternative to oral anticoagulation therapy. The Watchman FLX pro, a self-expanding device, is implanted in the LAA to stop blood clots from forming. In September 2022, US manufacturer Boston Scientific Corporation gained approval from the Food and Drug Administration in the US for the Watchman FLX to minimize stroke risk in NVAF patients. The device’s design allows for easier implantation compared to its predecessors, expanding its applicability to a wider range of patients. It remains a safe and effective stroke prevention method for NVAF sufferers, and a worthwhile option for those unable to handle oral anticoagulation therapy or deemed unsuitable for it.
View the full report here:
How Is the Left Atrial Appendage Closure Device Market Defined and What Are Its Core Parameters?
A left atrial appendage closure device is a medical implant used to treat certain heart conditions, specifically in atrial fibrillation (AF) patients. These devices are implanted in a minimally invasive surgery to lower the risk of stroke in AF patients by sealing off or occluding the left atrial appendage (LAA), preventing blood from entering and clotting.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13474
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
